Literature DB >> 31447534

Evaluation of a Pharmacist-Driven Protocol to Reduce Inappropriate Use of Acid-Suppressive Medications In the Non-ICU Setting.

Tracey L Mersfelder, Chris Jacob, Jason K Lam, Kevin J Kavanaugh, Christin M Molnar.   

Abstract

PURPOSE: Proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2 blockers) continue to be over utilized for stress ulcer prophylaxis (SUP). Our study aims to evaluate the effectiveness and feasibility of a pharmacist-driven termination protocol in a community teaching hospital to limit the inappropriate use of acid-suppressive medications in the non-intensive care unit (ICU) setting.
METHODS: Patient charts were evaluated for the appropriate use of PPIs or H2 blockers. A centralized pharmacist contacted healthcare providers for medication discontinuation if the acid suppressant use was deemed inappropriate. The primary outcome of the study was the number of patients who had acid-suppressive medication discontinued after the implementation of the pharmacist-driven termination protocol.
RESULTS: Acid-suppressive medication was inappropriately prescribed for nine patients. It was discontinued for eight of those patients based on the pharmacist-driven termination protocol; this was a statistically significant decrease (P < 0.001). The pharmacist spent, on average, less than one minute on each patient's chart.
CONCLUSION: Our study revealed that a pharmacist-driven termination protocol resulted in a 6% overall reduction rate in inappropriately used acid-suppressive medications, with little impact on pharmacist workflow. Implementing such a termination protocol could help to decrease the inappropriate use of acid-suppressive medications in an inpatient hospital service.

Entities:  

Keywords:  antagonists; histamine-2; pharmacist; proton pump inhibitors; quality improvement

Year:  2019        PMID: 31447534      PMCID: PMC6679947     

Source DB:  PubMed          Journal:  P T        ISSN: 1052-1372


  15 in total

1.  ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998.

Authors: 
Journal:  Am J Health Syst Pharm       Date:  1999-02-15       Impact factor: 2.637

2.  Descriptive analysis of a clinical pharmacy intervention to improve the appropriate use of stress ulcer prophylaxis in a hospital infectious disease ward.

Authors:  Hossein Khalili; Simin Dashti-Khavidaki; Azita Haj Hossein Talasaz; Hamed Tabeefar; Narjes Hendoiee
Journal:  J Manag Care Pharm       Date:  2010-03

3.  Interventions to curb the overuse of Acid-suppressive medications on an inpatient general medicine service.

Authors:  Randolph E Regal; Amanda D Osta; Vikas I Parekh
Journal:  P T       Date:  2010-02

4.  Acid suppressive therapy use on an inpatient internal medicine service.

Authors:  Co Q D Pham; Randolph E Regal; Thomas R Bostwick; Kara S Knauf
Journal:  Ann Pharmacother       Date:  2006-06-27       Impact factor: 3.154

5.  Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients.

Authors:  Mitchell S Buckley; Andrew S Park; Clint S Anderson; Jeffrey F Barletta; Dale S Bikin; Richard D Gerkin; Cheryl W O'Malley; Laura M Wicks; Roxanne Garcia-Orr; Sandra L Kane-Gill
Journal:  Am J Med       Date:  2015-03-27       Impact factor: 4.965

6.  Impact of a pharmacist-driven warfarin management protocol on achieving therapeutic International Normalized Ratios.

Authors:  Amanda Downing; Molly Mortimer; Jill Hiers
Journal:  Am J Health Syst Pharm       Date:  2016-03-01       Impact factor: 2.637

7.  Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization.

Authors:  Lisa Thomas; Eric J Culley; Patricia Gladowski; Vickie Goff; John Fong; Sarah M Marche
Journal:  J Manag Care Pharm       Date:  2010-03

8.  Development of a pharmacist-driven protocol for automatic medication dosage adjustments in obese patients.

Authors:  Justine M Russell; Rebecca L Nick-Dart; Brandon D Nornhold
Journal:  Am J Health Syst Pharm       Date:  2015-10-01       Impact factor: 2.637

9.  Impact of Clostridium difficile-associated diarrhea on acute care length of stay, hospital costs, and readmission: A multicenter retrospective study of inpatients, 2009-2011.

Authors:  Glenn Magee; Marcie E Strauss; Sheila M Thomas; Harold Brown; Dorothy Baumer; Kelly C Broderick
Journal:  Am J Infect Control       Date:  2015-11       Impact factor: 2.918

10.  Description and process evaluation of pharmacists' interventions in a pharmacist-led information technology-enabled multicentre cluster randomised controlled trial for reducing medication errors in general practice (PINCER trial).

Authors:  Rachel Howard; Sarah Rodgers; Anthony J Avery; Aziz Sheikh
Journal:  Int J Pharm Pract       Date:  2013-05-30
View more
  1 in total

1.  Current practice of stress ulcer prophylaxis in a surgical patient cohort in a German university hospital.

Authors:  Julia Rauch; Maciej Patrzyk; Claus-Dieter Heidecke; Tobias Schulze
Journal:  Langenbecks Arch Surg       Date:  2021-09-14       Impact factor: 3.445

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.